Laan M, Prause O, Miyamoto M, Sjöstrand M, Hytönen A M, Kaneko T, Lötvall J, Lindén A
Lung Pharmacology Group, Dept of Respiratory Medicine and Allergology, Institute of Internal Medicine, Göteborg University, Gothenburg, Sweden.
Eur Respir J. 2003 Mar;21(3):387-93. doi: 10.1183/09031936.03.00303503.
The T-cell cytokine interleukin (IL)-17 selectively accumulates neutrophils in murine airways in vivo and may thus constitute a link between activation of T-lymphocytes and accumulation of neutrophils. In this study, the authors evaluated the role of granulocyte macrophage-colony stimulating factor (GM-CSF) in accumulation of neutrophils in the airways caused by IL-17 and tumour necrosis factor (TNF)-alpha. In vitro, human (h) IL-17 concentration-dependently stimulated the release of GM-CSF protein (enzyme-linked immunosorbent assay) in human bronchial epithelial cells (16HBE). IL-17 also time-dependently stimulated the release of GM-CSF protein in venous endothelial (human umbilical vein endothelial cells) cells in vitro. Co-stimulation with IL-17 plus the pro-inflammatory cytokine TNF-alpha potentiated the release of GM-CSF protein in 16HBE cells. hIL-17 also enhanced the expression of GM-CSF messenger ribonucleic acid in 16HBE cells (reverse transcriptase polymerase chain reaction), with a similar order of magnitude as TNF-alpha. Conditioned cell medium from bronchial epithelial cells co-stimulated with hIL-17 plus TNF-alpha prolonged survival (trypan blue exclusion) of human neutrophils in vitro and this effect was blocked by an anti-GM-CSF antibody. In vivo, local co-stimulation with mouse IL-17 plus TNF-alpha caused an additive potentiation of the accumulation of neutrophils in bronchoalveolar lavage fluid from mouse airways and this effect was blocked by an anti-GM-CSF antibody given systemically. In conclusion, granulocyte macrophage-colony stimulating factor is involved in the accumulation of neutrophils in the airways caused by interleukin-17 and tumour necrosis factor-alpha, probably via effects on both recruitment and survival of neutrophils.
T细胞细胞因子白细胞介素(IL)-17可在体内选择性地使中性粒细胞在小鼠气道中蓄积,因此可能构成T淋巴细胞激活与中性粒细胞蓄积之间的联系。在本研究中,作者评估了粒细胞巨噬细胞集落刺激因子(GM-CSF)在IL-17和肿瘤坏死因子(TNF)-α所致气道中性粒细胞蓄积中的作用。在体外,人(h)IL-17以浓度依赖的方式刺激人支气管上皮细胞(16HBE)释放GM-CSF蛋白(酶联免疫吸附测定)。IL-17在体外也能以时间依赖的方式刺激静脉内皮细胞(人脐静脉内皮细胞)释放GM-CSF蛋白。IL-17与促炎细胞因子TNF-α共同刺激可增强16HBE细胞中GM-CSF蛋白的释放。hIL-17还增强了16HBE细胞中GM-CSF信使核糖核酸的表达(逆转录聚合酶链反应),其数量级与TNF-α相似。与hIL-17加TNF-α共同刺激的支气管上皮细胞的条件培养基可延长体外人中性粒细胞的存活时间(台盼蓝排斥法),且这种作用可被抗GM-CSF抗体阻断。在体内,小鼠IL-17加TNF-α局部共同刺激可使小鼠气道支气管肺泡灌洗液中中性粒细胞的蓄积呈叠加性增强,且这种作用可被全身给予的抗GM-CSF抗体阻断。总之,粒细胞巨噬细胞集落刺激因子可能通过对中性粒细胞募集和存活的影响,参与了白细胞介素-17和肿瘤坏死因子-α所致气道中性粒细胞的蓄积。